GreyBird Ventures

As an early-stage venture capital firm, we invest in companies with technology for precision medicine diagnosis. The technologies in focus have the characteristics of very high specificity and the capability to dramatically improve the choice of optimum therapy and reduce cost. Our companies will have a well-protected IP position and management with deep domain knowledge and a sense of creative thrift. Founded by Michael Devlin and Tom Miller, we are in the early stages of fund-raising but already have investments in prototypical portfolio companies. We have also recruited a team of eight operating advisors located in North America, Europe, and Asia with extremely deep domain expertise and operating experience.